Back
ESC Professional Premium Access

Influence of novel risk markers on defibrillator implantation in hypertrophic cardiomyopathy

Session: Electrocardiography and cardiomyopathies
Topic: Hypertrophic Cardiomyopathy
Speaker: Mr W. Procter (London, GB)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Mr William Procter

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Atrial fibrillation concerning worse prognosis in patients with left ventricular noncompaction

Speaker: Doctor W. Xu (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Promise or peril : The ECG in HCM

Speaker: Doctor H. Cronin (Cork, IE)

Access
Abstract
Slides
Like
Thumbnail

New-onset atrial fibrillation diagnosed by cardiac implantable devices in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis

Speaker: Doctor V. Hurtado (Miami, US)

Access
Abstract
Slides
Like
Thumbnail

3 year outcomes of permanent pacemaker implantation after alcoholic septal ablation

Speaker: Doctor A. Grazina (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Prognostic role of low QRS voltages in patients with cardiac amyloidosis

Speaker: Associate Professor F. Guerra (Ancona, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Electrocardiography and cardiomyopathies

Speakers: Mr W. Procter, Doctor W. Xu, Doctor H. Cronin, Doctor V. Hurtado, Doctor A. Grazina...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources